Fixing a Broken System: The Path to Public Pharma in New York

Public pharma is an alternative to our current profit-driven pharmaceutical system. Public pharma uses the public sector to research, develop, manufacture, and distribute drugs.

"Fixing a Broken System: The Path to Public Pharma in New York" is a critical discussion that will illuminate the transformative potential of publicly owned, manufactured, and distributed pharmaceuticals as we confront an industry that has prioritized profits over patients for too long, leaving patients without access to the medications they need to survive.

Join the Engelberg Center, the Health and Political Economy Project at the New School's Institute on Race, Power, and Political Economy, the NY #insulin4all Chapter, NYU Law's Science, Health, and Information Clinic, and T1International as we envision and collaborate on a future where life-saving medications are treated as public goods rather than commodities.

This future builds on a long history of public pharma in the United States and around the world. Community organizers with type 1 diabetes, legal advocates for patients, and legislative and policy leaders will examine how public control over pharmaceutical development, manufacturing, pricing, and distribution could redirect an industry that has prioritized revenue over patients for decades. Our discussion will focus on proposed legislation that would empower New York State to make and distribute low-cost insulin.

Click here to RSVP for your free ticket. Light refreshments will be provided.